F-star Therapeutics Appoints James Sandy as Chief Development Officer
Go back to F-star Therapeutics Appoints James Sandy as Chief Development Officer| (NASDAQ: FSTX) | Delayed: 7.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.12 | 52 Week High | $ | |||
| Open | $12.36 | 52 Week Low | $ | |||
| Day High | $7.12 | P/E | N/A | |||
| Day Low | $7.12 | EPS | $ | |||
| Volume | 1,067,673 | |||||
| (NASDAQ: IMCR) | Delayed: 30.18 +0.98 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.20 | 52 Week High | $ | |||
| Open | $29.60 | 52 Week Low | $ | |||
| Day High | $30.31 | P/E | N/A | |||
| Day Low | $29.60 | EPS | $ | |||
| Volume | 943,920 | |||||
